Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes
- PMID: 30520705
- PMCID: PMC6535962
- DOI: 10.1089/ten.TEA.2018.0272
Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes
Abstract
Genetic heart diseases such as arrhythmogenic cardiomyopathy (AC), a common genetic cause of sudden cardiac death, can be modeled using patient-specific induced pluripotent stem cell-derived cardiac myocytes (CMs). However, it is important to culture these cells in a multicellular syncytium with exposure to surrounding matrix cues to create more accurate and robust models of the disease due to the importance of cell-cell and cell-matrix interactions. The engineered heart slice, constructed by seeding CMs on intact decellularized matrix slices, allows molecular and functional studies on an aligned multilayered syncytium of CMs. This study reveals the potential for an improved disease-in-a-dish model of AC.
Keywords: arrhythmogenic cardiomyopathy; cardiomyocyte; decellularized matrix; disease modeling; engineered tissues; induced pluripotent stem cells.
Conflict of interest statement
None of the authors has any competing financial conflicts of interest to disclose.
Figures
References
-
- Hamlin R.L. Animal models of ventricular arrhythmias. Pharmacol Ther 113, 276, 2007 - PubMed
-
- Davis R.P., van den Berg C.W., Casini S., Braam S.R., and Mummery C.L. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol Med 17, 475, 2011 - PubMed
-
- Zeevi-Levin N., Itskovitz-Eldor J., and Binah O. Cardiomyocytes derived from human pluripotent stem cells for drug screening. Pharmacol Ther 134, 180, 2012 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
